SCHEMBL4676908

SCHEMBL4676908

CN(C)S(=O)(=O)N1CCN(S(=O)(=O)N2CCC(c3ccc(F)cc3)CC2)[C@@H](C(=O)NO)C1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 5/20 0.41
MMP3 P08254 4/20 0.41
MMP7 P09237 3/20 0.41
MMP9 P14780 3/20 0.41
MMP13 P45452 2/20 0.41
USP5 P45974 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MMP2 P08253 1/20 0.38
MMP8 P22894 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
ADAM17 P78536 1/20 0.36
LMNA P02545 1/20 0.36
NAMPT P43490 1/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7499676 1.00 MMP1 (0.41) MMP1MMP3MMP7MMP9MMP13
SCHEMBL4673266 0.86 USP5 (0.41) MMP1MMP3MMP7MMP9MMP13
SCHEMBL4675374 0.84 SMN1; SMN2 (0.45) MMP1MMP3MMP7MMP9MMP13
SCHEMBL4673474 0.81 MMP1 (0.53) MMP1MMP3MMP7MMP9MMP13
SCHEMBL4673925 0.80 LMNA (0.43) MMP1MMP3MMP7MMP9MMP13
SCHEMBL4674820 0.80 LMNA (0.43) MMP1MMP3MMP7MMP9MMP13
SCHEMBL4673740 0.80 USP5 (0.42) MMP1MMP3MMP7MMP9MMP13
SCHEMBL4676535 0.79 MMP1 (0.52) MMP1MMP3MMP7MMP9MMP13
SCHEMBL4674797 0.78 MMP1 (0.35) MMP1MMP3MMP7MMP9MMP13
SCHEMBL4675290 0.78 LMNA (0.51) MMP1MMP3MMP7MMP9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0958287-B2 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2008-04-09 EP disclosed
EP-0958287-B1 SULFAMIDE-METALLOPROTEASE INHIBITORS HOFFMANN LA ROCHE (CH) 2002-09-11 EP disclosed
US-6376506-B1 REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS SYNTEX (U.S.A.) LLC 2002-04-23 US disclosed
US-6143744-A Sulfamide-metalloprotease inhibitors SYNTEX (U.S.A.) INC. (US) 2000-11-07 US disclosed
US-6130220-A ENZYME INHIBITORS SYNTEX (USA) INC. (US) 2000-10-10 US disclosed
US-5998412-A ANTIARTHRITIC AGENTS; OSTEOPOROSIS SYNTEX (U.S.A.) INC. (US) 1999-12-07 US disclosed